27-Mar-2024
PRNewswire (Wed, 27-Mar 7:53 PM ET)
Merck's $11B Bet Pays As FDA Approves Sotatercept For Rare Lung Disease
Benzinga (Wed, 27-Mar 9:20 AM ET)
BTIG upgrades Nuvation to buy, cites AnHeart acquisition
Seeking Alpha News (Tue, 26-Mar 1:37 PM ET)
Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes
Business Wire (Tue, 26-Mar 6:59 AM ET)
Business Wire (Mon, 25-Mar 8:00 AM ET)
InvestorBrandMedia (Thu, 21-Mar 7:20 PM ET)
Business Wire (Wed, 20-Mar 4:45 PM ET)
Business Wire (Wed, 20-Mar 6:59 AM ET)
Business Wire (Tue, 19-Mar 6:59 AM ET)
Business Wire (Mon, 18-Mar 9:52 AM ET)
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
Bristol-Myers Squibb Company trades on the NYSE stock market under the symbol BMY.
As of March 27, 2024, BMY stock price climbed to $53.25 with 9,807,112 million shares trading.
BMY has a beta of 0.35, meaning it tends to be less sensitive to market movements. BMY has a correlation of 0.04 to the broad based SPY ETF.
BMY has a market cap of $107.68 billion. This is considered a Large Cap stock.
Last quarter Bristol-Myers Squibb Company reported $11 billion in Revenue and $1.70 earnings per share. This beat revenue expectation by $285 million and exceeded earnings estimates by $.17.
In the last 3 years, BMY stock traded as high as $81.44 and as low as $47.58.
The top ETF exchange traded funds that BMY belongs to (by Net Assets): VTI, VOO, SCHD, SPY, IVV.
BMY has underperformed the market in the last year with a price return of -18.4% while the SPY ETF gained +33.6%. BMY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +5.2% and +1.1%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
BMY support price is $51.84 and resistance is $53.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BMY stock will trade within this expected range on the day.